Completed PHASE2 INTERVENTIONAL 2-arm NCT04113889

Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome (PCOS)

Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress Response in Patients With PCOS: A Double Blind Randomized Clinical Trial

Sponsor: Khyber Medical University Peshawar

Conditions PCOS

Interventions Metformin (1000 mg daily), Pioglitazone (30 mg daily), Acetyl-L-carnitine (3 gm daily) Metformin, pioglitazone and placebo

Updated 6 times since 2019 Last updated: Jan 30, 2020 Started: Oct 15, 2019 Primary completion: Jan 30, 2020 Completion: Jan 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on PCOS, this trial is completed. The trial is conducted by Khyber Medical University Peshawar and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Mar 2020 — Jan 2021 [monthly]

Completed PHASE2

Status: Recruiting → Completed · Phase: PHASE4 → PHASE2
Dec 2019 — Mar 2020 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Nov 2019 — Dec 2019 [monthly]

Not Yet Recruiting PHASE4

First recorded

Oct 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Khyber Medical University Peshawar

Data source: Khyber Medical University Peshawar

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Peshawar, Pakistan